TZPBC HealthTech – Welcome to TZPBC HealthTech

The Bridge to Healthy Ageing in Asia

TZPBC’s Healthy Ageing Impact Ventures was founded on the belief that harnessing technology to achieve healthy ageing in Asia presents the greatest opportunity for investment and social good of our time

We invest at the intersection of
three foundational health trends

TZPBC’s Investment Pillars

We invest in entrepreneurs and technologies that:

Place Seniors at the Center
of Their Health

Precision Medicine. Genomics, novel biomarkers, systems medicine for community diagnosis and treatment

Digital Therapeutics. DTx and digital rehabilitation force a rethink of how we treat disease, facilitate broader access to care

Empowered Health Consumers. Tools that give seniors greater control over their health

Expand the Role of
the Community
Health Enterprise

Enterprise Telehealth. Beyond video, telehealth means true interoperability of health data

Analytic Decision Frameworks. Proactive risk management, tracking population outcomes and health system performance

Data Stewardship. Security and stewardship paramount to enabling digital health impact

Empower Seniors to Stay Independent for Longer

Remote Monitoring. Biometric wearables and sensors enable maintenance of wellness

Caregiver Coordination and Support. Improve training and quality of life for caregivers, families and the patients they assist

Digital Purpose and Companionship. Software to address loneliness and isolation

Singapore Centers of Excellence

We Bridge Entrepreneurs into the Asia Market

Global Thought Leadership. Uniting stakeholders from government, health systems, academia and industry to build an information advantage and forge new models of care for the Asia region

Pilot Initiatives. Designing proof of concept, proof of value initiatives to accelerate validation and adoption of promising technologies

Rapid Scaling. Scaling of technologies across the Asia region including within ‘Smart City’ projects

Global Investment Scope

Through a disciplined investment process and global sourcing capability, we identify digital health entrepreneurs seeking to grow their footprint in the Asia region

Sourcing Networks:

Global

Target Stage:

Early to Mid-Stage
Growth

Disciplined Process:

Information Advantage / Proprietary Insights

TZPBC's Team - Building Effective Bridges

We have assembled a diverse senior management team of leading global innovators across health, technology, finance, and industry. This core multi-disciplinary group has engaged our global network of internationally renowned clinicians, scientists, finance professionals and government stakeholders to enhance our industry knowledge and insights and support leading entrepreneurs and innovators

Our Founders

Wee Theng Tan

Co-Founder, Singapore

Former President, Intel China

Jackson Cheng

Co-Founder, Hong Kong

Serial Entrepreneur

Andrew Economos

Co-Founder, Singapore

Former CIO & Head, Principal Strategies, Asia, JP Morgan

Paul Scibetta

Co-Founder, New York

Former CEO, JP Morgan Private Bank, Asia

Our Leadership Team

Dr. Pinchas Cohen

Ageing

Dean, USC Leonard Davis School of Gerontology

Dr. Stephen Gruber

Precision Medicine

Director of Precision Medicine and VP, City of Hope National Medical Center

Louise Roman

General Counsel

Former Partner, Dechert LLP

Dr. James Best

Chief Scientific Advisor, Singapore

Former Dean, Lee Kong Chian School of Medicine, NTU Singapore

Dr. Gil Omenn

Chief Scientific Advisor, US

Former Director, Amgen

Former CEO, University of Michigan Health System

Carey Cheung

Strategic Relations

Former Head of Hong Kong, JP Morgan Wealth Management

Our Principal Advisors

Jamie Broderick

Senior Advisor

Founder, Impact Investing Institute; Ex-CEO, UBS Private Bank, UK

Michelle Bucaria

Industry Advisor

Chief People Officer, PointClickCare

Mike O’Brien

Senior Advisor

Former Head of Solutions, JP Morgan Asset Management

Larry Smith

Senior Advisor

Former CIO, Credit Suisse Asset Management

Dr. Yen Yun

Science Advisor

Former President, Taipei Medical University

Dr. Mitchell Lew

Industry Advisor

President, Prospect Medical Holdings

Dr. Gadi Rennert

Science Advisor

Director, Clalit Nat. Cancer Center & Personalized Medicine Program, Israel

Dr. Aaron Fenster

Science Advisor

CEO & Chief Scientific Officer for CIMTEC

Dr. Brian Athey

Science Advisor

Chair, Dept. of Computational Medicine & Bioinformatics, University of Michigan

TZPBC & St Luke’s Hospital

A Stepped-Up Person-Centric Smart Dementia Management System in Action

The integrated value-based Dementia care model aims to improve patients’ outcomes and cost-effectiveness across the healthcare continuum.

The system emphasises a holistic approach from early detection and intervention; to higher intensity in-patient care; to long-term community and caregiver support.

TZPBC partners with St Luke’s Hospital to implement a Dementia Care System with its medical science and systems experts, producing a virtual telehealth delivery system incorporating :

Dementia tech
Data management
Remote patient monitoring systems

The Bridge to Healthy Ageing in Asia

We invest at the intersection ofthree foundational health trends

TZPBC’s Investment Pillars

Place Seniors at the Center of Their Health

Expand the Role of the Community Health Enterprise

Empower Seniors to Stay Independent for Longer

Singapore Centers of Excellence

Global Investment Scope

TZPBC's Team - Building Effective Bridges

Wee Theng Tan

Co-Founder, Singapore

Former President, Intel China

Jackson Cheng

Co-Founder, Hong Kong

Serial Entrepreneur

Andrew Economos

Co-Founder, Singapore

Former CIO & Head, Principal Strategies, Asia, JP Morgan

Paul Scibetta

Co-Founder, New York

Former CEO, JP Morgan Private Bank, Asia

Dr. Pinchas Cohen

Ageing

Dean, USC Leonard Davis School of Gerontology

Dr. Stephen Gruber

Precision Medicine

Director of Precision Medicine and VP, City of Hope National Medical Center

Louise Roman

General Counsel

Former Partner, Dechert LLP

Dr. James Best

Chief Scientific Advisor, Singapore

Former Dean, Lee Kong Chian School of Medicine, NTU Singapore

Dr. Gil Omenn

Chief Scientific Advisor, US

Former Director, Amgen

Former CEO, University of Michigan Health System

Carey Cheung

Strategic Relations

Former Head of Hong Kong, JP Morgan Wealth Management

Jamie Broderick

Senior Advisor

Founder, Impact Investing Institute; Ex-CEO, UBS Private Bank, UK

Michelle Bucaria

Industry Advisor

Chief People Officer, PointClickCare

Mike O’Brien

Senior Advisor

Former Head of Solutions, JP Morgan Asset Management

Larry Smith

Senior Advisor

Former CIO, Credit Suisse Asset Management

Dr. Yen Yun

Science Advisor

Former President, Taipei Medical University

Dr. Mitchell Lew

Industry Advisor

President, Prospect Medical Holdings

Dr. Gadi Rennert

Science Advisor

Director, Clalit Nat. Cancer Center & Personalized Medicine Program, Israel

Dr. Aaron Fenster

Science Advisor

CEO & Chief Scientific Officer for CIMTEC

Dr. Brian Athey

Science Advisor

Chair, Dept. of Computational Medicine & Bioinformatics, University of Michigan

TZPBC & St Luke’s Hospital

A Stepped-Up Person-Centric Smart Dementia Management System in Action

Contact Us

Thank you for your enquires.

We will respond to you soonest possible.

PRINCIPAL

SCIENTIFIC

ADVISOR

Larry Smith

Fund Advisor

Former Global Head of Asset Allocation, JP Morgan

Anne Trevisan

Senior Advisor

We invest at the intersection of
three foundational health trends

Place Seniors at the Center
of Their Health

Expand the Role of
the Community
Health Enterprise

Serial
Entrepreneur